Expanded and Product Portfolio Strengthens Offering in Access and Therapy Guidance CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE Mark Approval for a broad suite of […]
Rhythm
Galaxy Medical and Japan Lifeline Enter Distribution Agreement For Novel Pulsed Electric Field Focal Ablation Catheter
SAN CARLOS, Calif., May 12, 2021 /PRNewswire/ — Galaxy Medical (Galaxy) and Japan Lifeline (JLL) today announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the United States, developed by Japan Lifeline for use with the Galaxy CENTAURI™ Pulsed Electric Field (PEF) System. Under the terms of the agreement, Galaxy will pursue US […]
Eko’s AI Analysis Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs
Peer-reviewed publication in the Journal of the American Heart Association found the AI algorithm detects clinically significant murmurs comparable to expert cardiologists OAKLAND, Calif., May 10, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced the peer-reviewed publication of a clinical study that found that the Eko artificial intelligence (AI) […]
Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial
– A new, first-of-its-kind study known as TAP-CHF leverages expertise across Abbott’s cardiovascular portfolio to optimize treatment for patients suffering from both AFib and heart failure – The trial will utilize Abbott technology including cardiac ablation and sensors to monitor for both pulmonary artery pressure and abnormal heartbeats – Historically, […]
Hicuity Health Honored with MedTech Breakthrough Award for Second Consecutive Year
Company Earns “Best Hospital Technology Implementation” Recognition for System-Wide Expansion of Rhythm CI Remote Telemetry ST. LOUIS, May 6, 2021 /PRNewswire/ — Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, announced that the company has been recognized by MedTech Breakthrough for the second consecutive year. The company earned recognition for the “Best Hospital […]
Eko Recognized for Artificial Intelligence Innovation in Healthcare with 2021 MedTech Breakthrough Awards
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies OAKLAND, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced that it has been selected as the winner of the “Best Use of Artificial Intelligence in Healthcare” award in the fifth annual MedTech […]
The Feasibility of 12-Lead Computational Analysis in Patients after COVID-19 Infection, using Vektor Medical’s vMap™, presented at Taiwan Heart Rhythm Society (THRS) 2021 Cutting-Edge Care for Heart Rhythm
vMap™ was presented as a technology that was able to provide arrhythmia insights for patients following COVID-19 infection, beyond those available from a standard 12-lead ECG CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a single-center study conducted at the University of California San Diego reports that use of vMap™ (computational 12-lead ECG analysis) […]
Biobeat’s AI-Powered Remote Patient Monitoring Platform Receives A Full CE Mark
Remote Patient Monitoring Platform Provides Continuous Vital Sign Measurement and Patient Deterioration Identification Capabilities In Hospital and Home Settings PETAH TIKVA, Israel , May 4, 2021 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that its full AI-powered wearable remote patient monitoring platform has received a […]
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) — The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases to date Currently conducting patient cases in 9 medical centers […]
FineHeart Breaks New Ground With Successful Removal of the ICOMS FLOWMAKER® in a 90-day In-vivo Trial
Towards a new standard for device indication: Implantation for temporary or permanent use Easy removal with a beating heart without damage to the myocardium 30 days after implantation Normal heart functioning 60 days after explantation Completely sealed operation with dedicated implant fixation system Quick recovery and short hospital stay Autonomy […]



